Opinions of gastroenterologists about intestinal microbiota modulating agents: results of the survey in focus groups

Aim. To study the opinions of gastroenterologists about drugs affecting intestinal microflora.
 Materials and methods. A qualitative survey was conducted in focus groups to patterns prescribing that regulate microflora chronic gastrointestinal diseases. The included only outpatient who managed patients with irritable bowel syndrome, an uncomplicated diverticular disease clinical manifestations excessive bacterial growth small intestine for at least 3 years.
 Results. Physicians perceive non-absorbable antibiotic rifaximin alpha as drug choice treating these diseases; they are aware its low bioavailability suitability repeated use. However, severe symptoms, some doctors tend use systemic antibiotics before infectious or inflammatory complications confirmed. It is due erroneous perception obviously more effective than antibiotics. When choosing a drug, it essential consider risk antibiotic-associated diarrhea, adverse changes microflora, patient's comorbidities.
 Conclusion. Surveyed alfa (Alfa Normix) most suitable helps routine practice achieve desired result minimum events. Many participants skeptical effect probiotics lack evidence but emphasize their safety request from patients. Not all metabiotics. Prebiotics dietary fibers perceived agents affect both stool frequency. Some healthcare professionals concerned prebiotics registered supplements, which can cause patient misunderstandings. Identified such be used training developing guidelines.